These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 88413)

  • 21. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative investigations of hydroxyethyl starch and dextran 60 in Isovolaemic haemodilution and haemorrhagic shock of rats (author's transl)].
    Hölscher B; Edeling M; Fahrmeier G; Kagel S
    Anaesthesist; 1975 May; 24(5):215-8. PubMed ID: 56902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].
    Thompson WL
    Infusionsther Klin Ernahr; 1979 Aug; 6(4):262-3. PubMed ID: 90652
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ascites as a complication of hepatic storage of hydroxyethyl starch in long-term dialysis].
    Pfeifer U; Kult J; Förster H
    Klin Wochenschr; 1984 Sep; 62(18):862-6. PubMed ID: 6208407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].
    Förster H; Wicarkzyk C; Dudziak R
    Infusionsther Klin Ernahr; 1981 Apr; 8(2):88-94. PubMed ID: 6164643
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
    Kiesewetter H; Jung F; Blume J; Gerhards M
    Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 29. Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension.
    Dienes HP; Gerharz CD; Wagner R; Weber M; John HD
    J Hepatol; 1986; 3(2):223-7. PubMed ID: 2432110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of physiological saline, dextran 70, hydroxyethyl starch, degraded gelatin, and fat emulsion solutions on screen filtration pressure.
    Elmér O; Göransson G; Saku M; Bengmark S
    Eur Surg Res; 1977; 9(2):85-95. PubMed ID: 67041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long term tolerance of highly dosed infusions of hydroxylethylstarch and dextran 60 in normovolemic rabbits].
    Hölscher B
    Infusionsther Klin Ernahr; 1975 Jun; 2(3):215-20. PubMed ID: 52620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyethyl starch.
    Thompson WL
    Prog Clin Biol Res; 1978; 19():283-92. PubMed ID: 78499
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.
    Hallaway PE; Eaton JW; Panter SS; Hedlund BE
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10108-12. PubMed ID: 2481311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.
    Mishler JM; Borberg H; Emerson PM; Gross R
    Br J Clin Pharmacol; 1977 Oct; 4(5):591-5. PubMed ID: 71913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of hydroxyethyl starch.
    Jungheinrich C; Neff TA
    Clin Pharmacokinet; 2005; 44(7):681-99. PubMed ID: 15966753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
    Mishler JM; Parry ES
    Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.